Kura Oncology, Inc.
Long

KURA:NASDAQ - KURA ONCOLOGY - Cancer biopharmaceutical company

98
KURA is up 500% from its March lows and running well. It has had a pullback and recovery and then an additional momentum bump on earnings. Could be worth a watch.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.